[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-364600-105":59,"doc-detail-364600-en":130},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":123,"head_meta":125,"extra_data":127,"updated_unix":129},105,"en","rbpms-inhibits-bladder-cancer-metastasis-by-downregulating-myc-pathway-through-alternative-splicing-of-ankrd10","RBPMS inhibits bladder cancer metastasis by downregulating MYC pathway through alternative splicing of ANKRD10","","RBPMS (an RNA-binding protein) is investigated as a regulator of alternative splicing in bladder cancer (BLCA) and its role in metastasis. Analysis of the TCGA-BLCA cohort identifies RBPMS as consistently downregulated among differentially expressed RNA-binding proteins and linked to unfavorable patient prognosis. Functional experiments show that RBPMS suppresses EMT signaling and the migratory behavior of BLCA cells. RNA-Seq highlights ANKRD10 as a key RBPMS target mRNA, where RBPMS depletion induces alternative splicing and increases ANKRD10-2 expression, which enhances MYC transcriptional activity. ANKRD10-2 knockdown rescues migration effects caused by RBPMS loss, supporting an RBPMS–ANKRD10–MYC splicing mechanism.",{"@graph":69,"@context":122},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/rbpms-inhibits-bladder-cancer-metastasis-by-downregulating-myc-pathway-through-alternative-splicing-of-ankrd10/364600/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/rbpms-inhibits-bladder-cancer-metastasis-by-downregulating-myc-pathway-through-alternative-splicing-of-ankrd10/364600.png","ImageObject",300,407,{"name":92,"@type":93},"Asher","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-10-28","2026-09-23",true,{"@type":102,"interactionType":103,"userInteractionCount":44},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118],{"name":109,"@type":110,"acceptedAnswer":111},"What is the main finding about RBPMS in bladder cancer?","Question",{"text":112,"@type":113},"RBPMS is consistently downregulated in bladder cancer and correlates with an unfavorable prognosis. Functionally, RBPMS inhibits EMT and reduces the migratory potential of BLCA cells.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"How was ANKRD10 identified in relation to RBPMS?",{"text":117,"@type":113},"RNA-Seq analysis identified ANKRD10 as a key target mRNA regulated by RBPMS in BLCA. RBPMS depletion alters ANKRD10 splicing and increases the ANKRD10-2 isoform.",{"name":119,"@type":110,"acceptedAnswer":120},"How does ANKRD10-2 connect to MYC signaling and migration?",{"text":121,"@type":113},"ANKRD10-2 acts as a transcriptional co-activator of MYC proteins, increasing MYC transcriptional activity. Knockdown of ANKRD10-2 significantly rescues the migration enhancement caused by RBPMS depletion.","https://schema.org",{"og:url":83,"og:type":124,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":126,"canonical":83},"index,follow",{"doc_id":128,"site_id":62},364600,1790196603,{"code":4,"msg":5,"data":131},{"doc_id":128,"user_id":132,"nickname":92,"user_avatar":133,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":44,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":139,"language":140,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":67,"update_tm":144,"read_time":145,"preview_page_count":19,"preview_urls":146},687197207639,"https://ap-avatar.wpscdn.com/davatar_a8503ba1806abce46bf441b54a3ca4cd","communications biology Article  \nA Nature Portfolio journal  \n[https://doi.org/10.1038/s42003-025-07842-1](https://doi.org/10.1038/s42003-025-07842-1)  \nRBPMS inhibits bladder cancer metastasis by downregulating MYC pathway through alternative splicing of ANKRD10  \n Check for updates  \n\n| Jingtian Yu1,2,3,8, Liang Chen  1,2,4,8, Gang Wang  Hang Zheng 1,3,7  & Mengxin Lu 1,2  | 5, Kaiyu Qian  | 5, Hong Weng1,6, Zhonghua Yang1,7, |\n| --- | --- | --- |\n| RNA-binding proteins (RBPs) are pivotal mediators of the alternative splicing (AS) machinery of premRNA. Research has demonstrated that the AS process is signiﬁcantly dysregulated and plays a crucial role in bladder cancer (BLCA) . We conducted comprehensive screening and analysis of the TCGA-BLCA cohort, speciﬁcally focusing on genes with signiﬁcant differences in expression levels between carcinoma and adjacent non-cancerous tissues. Among the 500 differentially expressed genes, 5 RNA-binding proteins were identiﬁed. Only the RNA-binding protein with multiple splicing (RBPMS) demonstrated a consistent downregulation in BLCA and was correlated with an unfavorable prognosis for affected patients. Subsequent experiments revealed that RBPMS exerted inhibitory effects on the epithelial-mesenchymal transition (EMT) pathway and the migratory potential of BLCA cells. RNA-Seq analysis identiﬁed ANKRD10 as a key target mRNA regulated by RBPMS in BLCA. RBPMS depletion in BLCA cells resulted in AS ofANKRD10 and increased ANKRD10-2 expression. ANKRD10-2 functioned as a transcriptional co-activator of MYC proteins, thereby augmenting their transcriptional activity. Furthermore, ANKRD10-2 knockdown signiﬁcantly rescued the migration enhancement induced by RBPMS depletion in BLCA cells. Taken together, this study revealed a mechanism whereby RBPMS suppresses the migration and invasion of BLCA cells by attenuating MYC pathway activity via the AS ofANKRD10 . |  |  |\n| Alternative splicing (AS) of pre-mRNA occurs in more than 95% of genes, enabling the generation of diverse protein structures and functions from a single gene1. The RNA spliceosome is responsible for this process and RNAbinding proteins(RBPs)playa crucial role in binding to speciﬁcmRNA2. AS has profound effects on cell differentiation and organ development under physiological conditions and is also implicated in various diseases, including cancer, autoimmune disease, and neurodegenerative diseases3. Dysregulation of RBPs expression can lead to alterations in target gene splicing, a key mechanism in tumorigenesis and development4,5. For instance, the functional role of RNA Binding Fox-1 Homolog 2 (RBFOX2) in AS has been |  | shown to suppress the metastatic progression of pancreatic cancer6. Research indicates that AS is signiﬁcantly dysregulated in bladder cancer (BLCA) and plays a crucial role in the development, progression, aggressiveness, and therapeutic resistance of this disease7.\u003Cbr>BLCA is the tenth most prevalent malignancy worldwide, exhibiting a male predilection with a fourfold higher incidence rate than that of females. Among males, BLCA is the sixth most common and ninth-most fatal malignancy8. Approximately 75% of BLCA cases are diagnosed as nonmuscle invasive BLCA (NMIBC). Despite advancements in both surgical and non-surgical interventions, the recurrence rate ofNMIBC remains high |\n\n1Department of Urology, Zhongnan Hospital of Wuhan University, Wuhan, China. 2Hubei Key Laboratory of Urological Diseases, Wuhan, China. 3Hubei Clinical Research Center for Laparoscopic/Endoscopic Urologic Surgery, Wuhan, China. 4Institute of Urology, Wuhan University, Wuhan, China. 5Department of Biological Repositories, Human Genetic Resources Preservation Center of Hubei Province, Hubei Key Laboratory of Urological Diseases, Zhongnan Hospital of Wuhan University, Wuhan, China. 6Center for Evidence-Based and Translational Medicine, Zhongnan Hospital of Wuhan University, Wuhan, China. 7Wuhan Clinical Research Center for Urogenital Tum","cbCaijYe0X9jPJ6h","https://ap.wps.com/l/cbCaijYe0X9jPJ6h","pdf",9478516,15,"English","# Background: alternative splicing and bladder cancer\n## Role of RNA-binding proteins in splicing dysregulation\n## Clinical burden and progression of BLCA\n# Discovery: RBPMS downregulation in BLCA\n## TCGA-BLCA screening of differentially expressed RBPs\n## Prognostic association and expression patterns\n# Mechanism: RBPMS regulates migration and EMT\n## Functional effects on EMT and migratory potential\n## Identification of ANKRD10 as a target\n# RBPMS–ANKRD10–MYC axis via alternative splicing\n## RBPMS depletion increases ANKRD10-2\n## ANKRD10-2 co-activates MYC transcription\n## Rescue by ANKRD10-2 knockdown","[{\"question\":\"What is the main finding about RBPMS in bladder cancer?\",\"answer\":\"RBPMS is consistently downregulated in bladder cancer and correlates with an unfavorable prognosis. Functionally, RBPMS inhibits EMT and reduces the migratory potential of BLCA cells.\"},{\"question\":\"How was ANKRD10 identified in relation to RBPMS?\",\"answer\":\"RNA-Seq analysis identified ANKRD10 as a key target mRNA regulated by RBPMS in BLCA. RBPMS depletion alters ANKRD10 splicing and increases the ANKRD10-2 isoform.\"},{\"question\":\"How does ANKRD10-2 connect to MYC signaling and migration?\",\"answer\":\"ANKRD10-2 acts as a transcriptional co-activator of MYC proteins, increasing MYC transcriptional activity. Knockdown of ANKRD10-2 significantly rescues the migration enhancement caused by RBPMS depletion.\"}]","RBPMS inhibits bladder cancer metastasis by downregulating MYC pathway through alternative splicing of ANKRD10 | PDF",1790158505,38,[147,151,155,159],{"page_no":8,"url":148,"width":149,"height":150},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/0ccbb242130776e74e56dc9ad61966d2.webp",983,1305,{"page_no":14,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/5dfd690c11cd52ba874f950787f20959.webp",982,1304,{"page_no":81,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/a0dbf2ec7dc225a1418de67329bb9662.webp",981,1303,{"page_no":19,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/e95f493a029415305bc9b612a5bb8a64.webp",980,1301]